Vincerx Pharma Inc
VINC
Market Cap$261.71K
Close$
$0.48
865.4% upside
Current Fair Value
865.4% upsideUndervalued by 865.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $261,714.00 |
|---|---|
| Enterprise Value | $-1,906,286.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-15.85 |
| Beta | 1.48 |
| Outstanding Shares | 3,580,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.07 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -1.19 |
| Debt to Equity | 1.1 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Vincerx Pharma Inc
28 employeesVincerx Pharma (Vincerx) is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment ...